L Jay Katz

Summary

Affiliation: Wills Eye Hospital
Country: USA

Publications

  1. ncbi Efficacy and safety of brimonidine and dorzolamide for intraocular pressure lowering in glaucoma and ocular hypertension
    L Jay Katz
    Glaucoma, Wills Eye Hospital, Philadelphia, PA 19107, USA
    Curr Med Res Opin 23:2971-83. 2007
  2. ncbi Fixed-combination brimonidine-timolol versus latanoprost in glaucoma and ocular hypertension: a 12-week, randomized, comparison study
    L Jay Katz
    Wills Eye Hospital, Philadelphia, PA, USA
    Curr Med Res Opin 28:781-8. 2012
  3. ncbi A clinical method to assess the effect of visual loss on the ability to perform activities of daily living
    Hong Wei
    Louis Esposito Research Professor, Glaucoma Research Center, Wills Eye Institute Jefferson Medical College, 840 Walnut Street, Suite 1110, Philadelphia, PA 19107, USA
    Br J Ophthalmol 96:735-41. 2012
  4. ncbi Knowledge of chronology of optic disc stereophotographs influences the determination of glaucomatous change
    Undraa Altangerel
    William and Anna Goldberg Glaucoma Service, Wills Eye Hospital, Jefferson Medical College, Philadelphia, Pennsylvania, USA
    Ophthalmology 112:40-3. 2005
  5. ncbi Effects of acutely lowering intraocular pressure on the results of multifocal visual evoked potential testing
    Anjana P Jindal
    Wills Eye Institute Glaucoma Service, Philadelphia, PA 19107 5599, USA
    Acta Ophthalmol 89:e550-4. 2011
  6. ncbi Twelve-month, randomized, controlled trial of bimatoprost 0.01%, 0.0125%, and 0.03% in patients with glaucoma or ocular hypertension
    L Jay Katz
    Wills Eye Hospital, Philadelphia, PA 19107, USA
    Am J Ophthalmol 149:661-671.e1. 2010
  7. ncbi Fixed combinations of dorzolamide-timolol and brimonidine-timolol in the management of glaucoma
    M Reza Razeghinejad
    Wills Eye Institute, Jefferson Medical College, Philadelphia, PA 19107, USA
    Expert Opin Pharmacother 11:959-68. 2010
  8. ncbi Selective laser trabeculoplasty versus medical therapy as initial treatment of glaucoma: a prospective, randomized trial
    L Jay Katz
    Glaucoma Service, Wills Eye Institute, Jefferson Medical College, Philadelphia, PA, USA
    J Glaucoma 21:460-8. 2012
  9. ncbi Pregnancy and glaucoma
    M Reza Razeghinejad
    Wills Eye Institute, Jefferson Medical College, Philadelphia, Pennsylvania, USA
    Surv Ophthalmol 56:324-35. 2011
  10. ncbi Comparison of human ocular distribution of bimatoprost and latanoprost
    Parul Ichhpujani
    Anne V Goldberg Glaucoma Service, Willis Eye Institute, Philadelphia, PA, USA
    J Ocul Pharmacol Ther 28:134-45. 2012

Collaborators

Detail Information

Publications32

  1. ncbi Efficacy and safety of brimonidine and dorzolamide for intraocular pressure lowering in glaucoma and ocular hypertension
    L Jay Katz
    Glaucoma, Wills Eye Hospital, Philadelphia, PA 19107, USA
    Curr Med Res Opin 23:2971-83. 2007
    ..Brimonidine and dorzolamide are intraocular pressure (IOP)-lowering medications most commonly used in second-line treatment of glaucoma and ocular hypertension...
  2. ncbi Fixed-combination brimonidine-timolol versus latanoprost in glaucoma and ocular hypertension: a 12-week, randomized, comparison study
    L Jay Katz
    Wills Eye Hospital, Philadelphia, PA, USA
    Curr Med Res Opin 28:781-8. 2012
    ..To evaluate the intraocular pressure (IOP)-lowering efficacy and safety of fixed-combination brimonidine 0.2%-timolol 0.5% compared with latanoprost 0.005% in patients with glaucoma or ocular hypertension...
  3. ncbi A clinical method to assess the effect of visual loss on the ability to perform activities of daily living
    Hong Wei
    Louis Esposito Research Professor, Glaucoma Research Center, Wills Eye Institute Jefferson Medical College, 840 Walnut Street, Suite 1110, Philadelphia, PA 19107, USA
    Br J Ophthalmol 96:735-41. 2012
    ..To develop a clinically applicable, performance-based measure of the ability to perform visually related activities...
  4. ncbi Knowledge of chronology of optic disc stereophotographs influences the determination of glaucomatous change
    Undraa Altangerel
    William and Anna Goldberg Glaucoma Service, Wills Eye Hospital, Jefferson Medical College, Philadelphia, Pennsylvania, USA
    Ophthalmology 112:40-3. 2005
    ..30+/-0.05 for masked evaluation). CONCLUSIONS: When disc photographs are read with knowledge of the chronology with which they were obtained, the observations differ considerably from when the readings are made without this knowledge...
  5. ncbi Effects of acutely lowering intraocular pressure on the results of multifocal visual evoked potential testing
    Anjana P Jindal
    Wills Eye Institute Glaucoma Service, Philadelphia, PA 19107 5599, USA
    Acta Ophthalmol 89:e550-4. 2011
    ..No studies to date have looked at improvement of multifocal visually evoked potentials (mfVEP) after lowering IOP...
  6. ncbi Twelve-month, randomized, controlled trial of bimatoprost 0.01%, 0.0125%, and 0.03% in patients with glaucoma or ocular hypertension
    L Jay Katz
    Wills Eye Hospital, Philadelphia, PA 19107, USA
    Am J Ophthalmol 149:661-671.e1. 2010
    ..To evaluate the intraocular pressure (IOP)-lowering efficacy and safety of ophthalmic formulations of bimatoprost 0.01% and 0.0125% compared with bimatoprost 0.03%...
  7. ncbi Fixed combinations of dorzolamide-timolol and brimonidine-timolol in the management of glaucoma
    M Reza Razeghinejad
    Wills Eye Institute, Jefferson Medical College, Philadelphia, PA 19107, USA
    Expert Opin Pharmacother 11:959-68. 2010
    ..Combination medications may also improve therapeutic efficacy and play an important role in controlling medication cost. However, the fixed dosing may be a disadvantage in some cases...
  8. ncbi Selective laser trabeculoplasty versus medical therapy as initial treatment of glaucoma: a prospective, randomized trial
    L Jay Katz
    Glaucoma Service, Wills Eye Institute, Jefferson Medical College, Philadelphia, PA, USA
    J Glaucoma 21:460-8. 2012
    ..To compare outcomes of selective laser trabeculoplasty (SLT) with drug therapy for glaucoma patients in a prospective randomized clinical trial...
  9. ncbi Pregnancy and glaucoma
    M Reza Razeghinejad
    Wills Eye Institute, Jefferson Medical College, Philadelphia, Pennsylvania, USA
    Surv Ophthalmol 56:324-35. 2011
    ..Glaucoma laser procedures, such as laser peripheral iridotomy and laser trabeculoplasty, have been employed without identifiable teratogenic effects or increased risk of side effects for pregnant women...
  10. ncbi Comparison of human ocular distribution of bimatoprost and latanoprost
    Parul Ichhpujani
    Anne V Goldberg Glaucoma Service, Willis Eye Institute, Philadelphia, PA, USA
    J Ocul Pharmacol Ther 28:134-45. 2012
    ..03% bimatoprost or 0.005% latanoprost for understanding concentration-activity relationships...
  11. ncbi The effects of Mozart's music on the performance of glaucoma patients on automated perimetry
    Bing Shue
    Glaucoma Service Wills Eye Institute, Philadelphia, Pennsylvania 19107, USA
    Invest Ophthalmol Vis Sci 52:7347-9. 2011
    ..A previous study showed improved reliability in normal subjects undergoing HVF testing...
  12. ncbi Canaloplasty for pigmentary glaucoma with coexisting conjunctival lymphoma
    Parul Ichhpujani
    Glaucoma Service, Wills Eye Institute, Philadelphia, Pennsylvania 19107, USA
    Ophthalmic Surg Lasers Imaging 42:e10-1. 2011
    ..This case report presents canaloplasty as a bleb-free surgical option for lowering intraocular pressure in cases with postoperative conjunctival scarring...
  13. ncbi Efficacy, safety, and current applications of brimonidine
    Scott J Fudemberg
    Wills Eye Institute, Instructor, Jefferson Medical College Anna and William Goldberg Glaucoma Service and Research Center, 840 Walnut St Ste 1130, Philadelphia, PA 19107, USA
    Expert Opin Drug Saf 7:795-9. 2008
    ..15 and 0.1%, Allergan, Inc., Irvine, CA, USA) and a fixed-combination mating brimonidine with timolol (Combigan, Allergan) evolved the marketing and application of this therapy...
  14. ncbi Twelve-month evaluation of brimonidine-purite versus brimonidine in patients with glaucoma or ocular hypertension
    L Jay Katz
    Brimonidine Purite Study Groups 1 and 2, Wills Eye Hospital, Philadelphia, Pennsylvania 19107 5599, USA
    J Glaucoma 11:119-26. 2002
    ..To compare the efficacy and safety of brimonidine-Purite (Alphagan; Allergan, Irvine, CA) 0.15% and 0.2% three times daily with brimonidine (Alphagan) 0.2% three times daily in patients with glaucoma or ocular hypertension...
  15. ncbi Single needle revision of failing filtration blebs: a retrospective comparative case series with 5-fluorouracil and mitomycin C
    Neal Palejwala
    William and Anna Goldberg Glaucoma Service, Wills Eye Institute, 840 Walnut Street, Philadelphia, PA 19107, USA
    Eur J Ophthalmol 20:1026-34. 2010
    ..To assess the success of needling in failed filtration blebs and the potential benefit of using either 5-fluorouracil (5-FU) or mitomycin C (MMC)...
  16. ncbi Bilateral angle closure glaucoma induced by sulphonamide-derived medications
    Grace C Lee
    Wills Eye Hospital, Thomas Jefferson Medical School, Philadelphia, PA, USA
    Clin Experiment Ophthalmol 35:55-8. 2007
    ..We report the occurrence of bilateral angle closure glaucoma with sulphonamide-derived medications and highlight features of the presentation and treatment to assist in early diagnosis and management...
  17. ncbi Releasable suture technique
    Daniela S Monteiro de Barros
    Glaucoma Department, Wills Eye Institute, Jefferson Medical College, Philadelphia, PA 19107, USA
    J Glaucoma 17:414-21. 2008
    ..This review will assess the indications for using releasable sutures, with the consideration of their advantages and disadvantages, after trabeculectomy...
  18. ncbi Bimatoprost: establishing its role in glaucoma management
    L Jay Katz
    Glaucoma Service, Wills Eye Hospital, and Thomas Jefferson Medical University, Philadelphia, Pennsylvania 19107-5599, USA
    Surv Ophthalmol 49:S1-4. 2004
  19. ncbi Iatrogenic glaucoma secondary to medications
    M Reza Razeghinejad
    Wills Eye Institute, Jefferson Medical College, Philadelphia, PA 19107, USA
    Am J Med 124:20-5. 2011
    ..The risk is higher with topical rather than systemic steroids. The first step in the management is discontinuation of the drug, followed by medical, laser, and, if necessary, surgical intervention...
  20. ncbi Ultrasound biomicroscopy and management of late posterior migration of a ripcord suture after glaucoma drainage implant surgery
    Paul J Harasymowycz
    Ana and William Goldberg Glaucoma Service, Wills Eye Hospital, Philadelphia, Pennsylvania 19107, USA
    Ophthalmic Surg Lasers Imaging 35:149-51. 2004
    ..Posterior ripcord migration is a rare complication after glaucoma drainage implant surgery, and ultrasound biomicroscopy imaging may be helpful in determining its proper management...
  21. ncbi The disc damage likelihood scale: reproducibility of a new method of estimating the amount of optic nerve damage caused by glaucoma
    George L Spaeth
    William and Anna Goldberg Glaucoma Research Laboratories, Wills Eye Hospital, Jefferson Medical College, Philadelphia, Pennsylvania, USA
    Trans Am Ophthalmol Soc 100:181-5; discussion 185-6. 2002
    ..CONCLUSION: In a clinical setting, the DDLS is as reproducible as, or more reproducible than, the c/d ratio system of estimating the amount of disc damage in patients with glaucoma...
  22. ncbi Cataract surgery with trabecular micro-bypass stent implantation in patients with mild-to-moderate open-angle glaucoma and cataract: two-year follow-up
    E Randy Craven
    Glaucoma Consultants of Colorado, Parker, Colorado, USA
    J Cataract Refract Surg 38:1339-45. 2012
    ..To assess the long-term safety and efficacy of a single trabecular micro-bypass stent with concomitant cataract surgery versus cataract surgery alone for mild to moderate open-angle glaucoma...
  23. ncbi Imaging modalities for localization of an iStent(®)
    Parul Ichhpujani
    William and Anna Goldberg Glaucoma Service, Wills Eye Institute, Philadelphia, PA, USA
    Ophthalmic Surg Lasers Imaging 41:660-3. 2010
    ..B-scan ultrasonography is unable to identify iStent in either the anterior or posterior chamber...
  24. ncbi Prevalence of the use of complementary and alternative medicine for glaucoma
    Douglas J Rhee
    Glaucoma Service, Wills Eye Hospital, Thomas Jefferson University, 900 Walnut Street, Philadelphia, PA 19107, USA
    Ophthalmology 109:438-43. 2002
    ..CONCLUSIONS: The prevalence of CAM use for glaucoma was 5.4% (95% confidence interval, 4.0%--6.4%). Most glaucoma patients currently cared for by ophthalmologists do not use nontraditional medicine...
  25. ncbi Releasable suture techniques for trabeculectomy: an illustrative review
    Jason B Wanner
    Glaucoma Service, Wills Eye Hospital, Philadelphia, Pennsylvania, USA
    Ophthalmic Surg Lasers Imaging 35:465-74. 2004
  26. ncbi Effectiveness of nonocclusive ligature and fenestration used in Baerveldt aqueous shunts for early postoperative intraocular pressure control
    Sukesh Kansal
    Wills Eye Hospital, Glaucoma Section, Philadelphia, Pennsylvania 19107, USA
    J Glaucoma 11:65-70. 2002
    ....
  27. ncbi Intracameral recombinant tissue plasminogen activator for refractory glaucoma secondary to a fungal corneal abscess
    L Jay Katz
    Wills Eye Institute, 840 Walnut Street, Philadelphia, USA
    Open Ophthalmol J 3:75-6. 2009
    ..The intraocular pressure dropped dramatically from 48 mmHg to 10 mmHg postoperatively, negating the need for glaucoma surgery...
  28. ncbi Bimatoprost/timolol fixed combination: a 3-month double-masked, randomized parallel comparison to its individual components in patients with glaucoma or ocular hypertension
    James D Brandt
    University of California, Davis, Sacramento, CA 95817 2307, USA
    J Glaucoma 17:211-6. 2008
    ..To evaluate the safety and efficacy of a fixed combination (FC) of bimatoprost (BIM) and timolol (TIM) compared with each of the active components for 3 months...
  29. ncbi Modern alchemy: fixed combinations of glaucoma drugs
    L Jay Katz
    Am J Ophthalmol 140:125-6. 2005
  30. ncbi A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma
    Paul P Lee
    Duke University Medical Center, Durham, NC 27710, USA
    Arch Ophthalmol 124:12-9. 2006
    ..Based on these findings, a glaucoma treatment that delays the progression of disease could have the potential to significantly reduce the health economic burden of this chronic disease over many years...
  31. ncbi Clinical agreement among glaucoma experts in the detection of glaucomatous changes of the optic disk using simultaneous stereoscopic photographs
    Augusto Azuara-Blanco
    Aberdeen Royal Infirmary, Scotland, Aberdeen, United Kingdom
    Am J Ophthalmol 136:949-50. 2003
    ..To evaluate the clinical agreement in the detection of optic disk changes in patients with glaucoma using simultaneous stereophotographs...
  32. ncbi Nanophthalmia and chronic angle-closure glaucoma
    Claude Burgoyne
    Glaucoma Service, LSU Eye Center, New Orleans, Louisiana 70112, USA
    J Glaucoma 11:525-8. 2002